Savitz Ryan
SEC CIK 1992324 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /DE/ | EVP, CFO, CBO | 31.2K | — | $14.99M | 10 | 2025-09-09 | 2026-07-09 |
Most active insiders at DNTH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Garcia Marino | CEO AND Pres, Dir | — | $27.96M |
| 2 | Randhawa Simrat | EVP, Head of R, D | — | $15.00M |
| 3 | Savitz Ryan | EVP, CFO, CBO | — | $14.29M |
| 4 | CARR EDWARD | CAO | — | $5.59M |
| 5 | Veness Adam M | SVP, GC, Sec | — | $4.63M |
| 6 | Soteropoulos Paula | Dir | — | $2.25M |
| 7 | McGeorge Anne | Dir | — | $844.8K |
| 8 | Read Simon | Dir | — | $630.8K |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-13 17:00 | 2026-07-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | EVP, CFO, CBO | M - OptEx | $21.77 | +31.2K | 31.2K | New | +$680.3K |
| DMT | 2026-07-13 17:00 | 2026-07-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | EVP, CFO, CBO | S - Sale+OE | $101.03 | -31.2K | 0 | -100% | -$3.16M |
| DT | 2026-04-10 16:52 | 2026-04-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | EVP, CFO, CBO | M - OptEx | $17.88 | +8,224 | 8,224 | New | +$147.0K |
| DT | 2026-04-10 16:52 | 2026-04-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | EVP, CFO, CBO | S - Sale+OE | $89.84 | -8,224 | 0 | -100% | -$738.8K |
| DMT | 2026-04-01 17:26 | 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | EVP, CFO, CBO | M - OptEx | $11.74 | +114.4K | 114.4K | New | +$1.34M |
| DMT | 2026-04-01 17:26 | 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | EVP, CFO, CBO | S - Sale+OE | $83.00 | -114.4K | 0 | -100% | -$9.49M |
| DT | 2025-12-05 | 2025-12-04 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO, CBO | S - Sale+OE | $45.18 | -20.0K | 0 | -100% | -$903.6K |
| DT | 2025-12-05 | 2025-12-04 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO, CBO | M - OptEx | $8.44 | +20.0K | 20.0K | New | +$168.8K |
| DT | 2025-09-11 | 2025-09-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO, CBO | S - Sale+OE | $35.00 | -20.0K | 0 | -100% | -$700.0K |
| DT | 2025-09-11 | 2025-09-09 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO, CBO | M - OptEx | $8.44 | +20.0K | 20.0K | New | +$168.8K |
Purchase Sale Sale after option exercise All abbreviations